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REVIEWCURRENTOPINION Enhanced cognitive behavioural therapy for patients
with eating disorders: a systematic review0951-7367 Copyright  2018 The Aa,b c,d a,e,fMartie de Jong , Maartje Schoorl , and Hans W. HoekPurpose of review
The aim of this study was to provide an update of the most recent (since January 2014) enhanced cognitive
behavioural therapy (CBT-E) effectiveness studies (randomized controlled trials and open trials) on bulimia
nervosa, binge eating disorder and transdiagnostic samples.
Recent findings
Out of 451 screened studies, seven effectiveness studies (five randomized and two open trials) were included
in this review: of these, three had a bulimia nervosa sample and four a transdiagnostic sample (all conducted
in an outpatient setting). Substantial differences in posttreatment remission rates were found (range: 22.2–
67.6%) due, in part, to differences in samples and operationalization of clinical significant change.
Summary
There is robust evidence that CBT-E is an effective treatment for patients with an eating disorder. However,
more studies on differential effects and working mechanisms are required to establish the specificity of CBT-E.
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Eating disorders are severe mental disorders, which
often begin in adolescence [1], frequently have a
chronic course [2] and can have considerable impact
on quality of life [3]. Eating disorders make a sub-
stantial contribution to the global burden of disease,
especially among young women [4]. Although
anorexia nervosa is a relatively rare disorder inmany
non-western countries, bulimia nervosa and binge
eating disorder (BED) are common disorders world-
wide [5]. Previous reviews showed that, among
young women in Europe, Asia, Africa and Latin
America, bulimia nervosa is reported by 1–2% and
BED by 1–4% [6–10]. Recent studies show that
eating disorders (especially bulimia nervosa and
BED) are also common among older persons; accord-
ing to the DSM-5 criteria, the prevalence of all eating
disorders combined is around 3.5% in older (aged
>40 years) women and around 1–2% in older men
[11]. Despite that increasing numbers of individuals
with eating disorders are receiving treatment, Euro-
pean samples show that only about one-third are
detected via healthcare [6].
In terms of the DSM-IV, the most common
eating disorder diagnosis in both clinical and com-
munity samples was ‘Eating disorder not otherwise
specified’ (EDNOS). With the introduction of theuthor(s). Published by Wolters KluweDSM-5 and concurrent changes in the eating disor-
der section (including the introduction of BED as an
official category, and lowering the threshold for
anorexia nervosa and bulimia nervosa), the percent-
age of ‘Other specified feeding or eating disorder’
(OSFED; DSM-IV EDNOS) was significantly reduced,
even though this diagnosis might still be the most
common one in this population [12–14].
According to a recent international comparison
between nine evidence-based clinical guidelines forr Health, Inc. www.co-psychiatry.com
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KEY POINTS
 There is robust evidence that CBT-E is an effective
treatment for adult patients with an eating disorder,
especially for bulimia nervosa, BED and OSFED.
 The substantial range in remission rates between studies
is partly due to differences in study samples and the
definition used for clinical significant change.
 Although IPT is an evidence-based treatment for bulimia
nervosa and BED, the first direct comparison between
IPT and CBT-E showed CBT-E to be more effective.
 CBT-E is a far more (cost-)effective treatment for bulimia
nervosa than psychoanalytic treatment on the main
parameters of bulimia nervosa, that is binge eating
and purging.
 Future research should focus on the working
mechanisms and differential effects of CBT-E compared
with other CBT protocols to establish the specificity of
CBT-E.
Eating disorderseating disorders, cognitive behavioural therapy
(CBT) is widely used as the preferred treatment for
bulimia nervosa and BED [15
&
]. The major guide-
lines for the treatment of eating disorders [16–18]
recommend CBT as the psychological treatment of
first choice for bulimia nervosa and BED. CBT-E
(enhanced) is a specific form of CBT and is designed
to be suitable for the full range of eating disorder
diagnoses [19]. It is based on the transdiagnostic
theory of the maintenance of eating disorders, in
which it is assumed that most of the mechanisms
involved in the persistence of eating disorders are
common to all eating disorders, rather than being
specific to each diagnostic group separately. It
asserts that central to all eating disorders is a dys-
functional evaluation of self-worth that is overly
based on shape and weight [20]. CBT-E uses strate-
gies and procedures to address this overevaluation of
shape and weight by focusing on targeting these
mechanisms (known as the ‘focused’ version of CBT-
E). The treatment protocol can be extended with
interventions that target additional maintaining
mechanisms, that is core low self-esteem, clinical
perfectionism and interpersonal problems (known
as the ‘broad’ version of CBT-E). For the OSFED
diagnoses, CBT-E has an advantage over other CBT
protocols because of its transdiagnostic reach. CBT-E
has been investigated in several samples in which
CBT-E for bulimia nervosa, BED and EDNOS proved
to be a successful treatment in the first studies after
development of the CBT-E protocol [21,22].
This review provides an update of the most
recent (i.e. published since 2014) CBT-E2 www.co-psychiatry.comeffectiveness studies [randomized controlled trials
(RCTs) and open trials] on bulimia nervosa, BED and
transdiagnostic samples. Studies on the transdiag-
nostic samples include bulimia nervosa, BED,
OSFED and, sometimes (i.e. in studies with lower
BMI inclusion criteria), anorexia nervosa. However,
excluded from the present review were studies with
an anorexia nervosa sample alone, due to differ-
ences in treatment duration and other treatment
variables (e.g. a focus on weight gain).
In this review, the characteristics of the included
studies are described, possible explanations for the
variability in outcome are proposed, recommenda-
tions are made for future research and the method-
ological quality of the RCTs is described. Due to the
small number of included studies, no meta-analysis
was performed.MATERIALS AND METHODS
Search strategy and study selection
The primary search strategy was made in Medline,
PsycInfo and EMBASE; the search covered the period
from January 2014 up to March 2018. The following
concepts were combined and searched for in the
title and abstract:(1) Eating Disorder OR disordered eat OR binge
eating disorder OR bulimia nervosa(2) Cognitive-behavioral OR CBT OR CBT-EArticles had to meet the following criteria: a
peer-reviewed study; including a sample that meets
the criteria for bulimia nervosa or BED, or a trans-
diagnostic sample with an eating disorder; and an
effectiveness study that includes (at least one con-
dition of) manualized CBT-E.
After removing duplicates, 451 articles (pub-
lished January 2014–March 2018) were selected.
The titles and abstracts of these articles were
screened by the first author. The full-text versions
of potential articles (n¼35) were read to check for
eligibility. The reference lists of the included articles
and reviews were also examined for relevant studies.
Finally, seven articles met the inclusion criteria
(Fig. 1).
This review also includes an assessment of the
methodological quality of the included RCTs. Tar-
rier and Wykes [23] developed the Clinical Trials
Assessment Test (CTAM), based on relevant features
from the CONSORT guidelines [24], to assess the
quality of trials of psychological treatments in men-
tal health. This test contains 15 items grouped into
six areas. Total scores range from 0 (no criterion isVolume 32  Number 00  Month 2018
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FIGURE 1. Flow diagram of inclusion of studies for this review.
Enhanced cognitive behavioural therapy de Jong et al.reached) to 100 (maximum score). The CTAM
has good blind inter-rater agreement and adequate
internal consistency [23].
Ratings were done by the first author and
one other independent rater. When required infor-
mation was missing, the first author contacted the
trial researchers for (possible) clarification.RESULTS
If data were not reported, a calculation was made
(when possible) based on the available data.Design









,29], and two were open trials0951-7367 Copyright  2018 The Author(s). Published by Wolters Kluwe[30,31
&
]. Of the two open trials, one specifically
aimed to find evidence that CBT-E is generalizable




All seven studies were conducted in an outpatient
setting. Three studies included participants who





]. Four studies also recruited participants
through distribution of information in local papers,












], two studies included partici-





one study included participants with bulimiar Health, Inc. www.co-psychiatry.com 3
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samples also included participants with anorexia
nervosa [29,31
&
]; this is explained by the use
of a variable low-range cut-off for BMI, ranging
substantially from 16 to 18.5. The Eating Disorder
Examination (EDE) [32] is generally regarded as the
gold standard in the assessment of an eating disor-









,29]. In one study, the
eating disorder was assessed by the treating thera-
pists on the basis of the DSM-IV criteria [31
&
], and in
one study, no information was provided on how the
eating disorder was diagnosed [30]. Most studies
included adults, although one study evaluated the
effects of CBT-E in a cohort of nonunderweight
adolescents [30]. Therewas a considerable difference
in the number of participants per study (see Table 1).Primary outcome measure and
operationalization of clinical significant
change
In all studies, the EDE [32], or its self-report version
(EDE-Q) [33], was used as the primary outcome









] and three the EDE-Q [29,30,31
&
]. In all four
studies using the EDE as primary outcome measure,









]. However, studies used dif-
ferent definitions of clinical significant change to
indicate relevant change (e.g. remission, good out-
come, abstinence, minimal residual eating disorder
psychopathology and so on) and different opera-
tionalizations of these concepts. In the studies with







from binges and purging was themain definition for
clinical significant change. In the transdiagnostic
samples, a global EDE-(Q) score less than 1 SD above
the community mean (sometimes combined with





] (Table 1). The two studies
conducted in Australia [29,31
&
] used different EDE-Q
norms; although both studies refer to Mond et al.
[34] for the norms used to indicate clinical signifi-
cant change (less than 1 SD above the community
mean, i.e. 2.77), the EDE-Q norms reported by
Signorini et al. [31
&
] were 2.46 or less.Cognitive behavioural therapy enhanced
variant
The seven included studies varied in the setting in
which therapy took place, whether the focused or
broad version of CBT-E was investigated, the dura-
tion of therapy and whether extra sessions were
planned involving significant others.4 www.co-psychiatry.comFour studies investigated the individual 20-ses-









]. In the study of Dalle Grave
et al. [30], parents were involved more closely, as
participants were adolescents; the parental involve-
ment consisted of five sessions of patients and
parents together. Details about which version of
CBT-E was investigated in this study were not
reported. Wade et al. [29] developed a treatment
manual for group CBT-E based on the individual
broad version of CBT-E including sessions to address
the additional maintaining mechanisms (i.e. core
low self-esteem, clinical perfectionism and interper-
sonal problems). Eighteen group sessions of 2h each
were offered (with 5–10min of individual work
before each group session), and two additional indi-
vidual sessions of 50min each. In the study of
Signorini et al. [31
&
], although CBT-E was investi-
gated according to the manual [19], there was vari-
ability in the number of sessions (40 sessions for
underweight participants, 20 sessions for nonunder-
weight participants) and also in the use of the
focused or the broad version of CBT-E.Control group
Of the five RCTs, three compared CBT-E with







study, CBT-E was compared with psychoanalytic
psychotherapy [25
&&
]. In the study of Wonderlich
et al. [26
&
], CBT-E was compared with a new psycho-
therapeutic treatment for bulimia nervosa, that is
integrative cognitive-affective therapy (ICAT). In
the study of Fairburn et al. [27
&&
], CBT-E was com-
pared with another evidence-based treatment for
bulimia nervosa: interpersonal psychotherapy
(IPT). In two of these three studies, the therapy





but in one study, the duration of therapy differed
greatly due to the nature of psychoanalytic psycho-
therapy [25
&&
], that is the psychoanalytic psycho-
therapy involved weekly sessions of 50 min each
over 2 years (mean number of sessions 72.3).
Thompson-Brenner et al. [28
&
] compared the
focused and broad version of CBT-E in persons with
comorbid bulimia nervosa and borderline personal-
ity disorder. In the RCT of Wade et al. [29], the
control group was a waiting list group; however,
in that study, only the first 8 weeks were controlled
for; after this period, the control group had a
delayed treatment start.Therapist competence/treatment integrity
In four of the seven studies, the founder of CBT-E
(Christopher Fairburn) or his colleague (ZafraVolume 32  Number 00  Month 2018
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Eating disordersCooper) was closely involved in the training and












]. In six studies, the frequency









,29,30]. In the study of Signorini et al.
[31
&
], the frequency of supervision was reported to
be ‘regular’. In three studies, the sessionswere audio-
recorded and a selection of these sessions was













]. The quality of the delivery of
the treatment condition was assessed by indepen-
dent raters using diverse adherence scales. In these
three studies, the raters scored adherence as ‘good’
[26
&





The operationalization of ‘completion’ also differs
between studies. In four studies, ‘completion’ was





,29,30]. Wonderlich et al. [26
&
] defined
completion as attending at least 16 sessions (of




], it is not clear how
completion was operationalized. Noncompletion
rates ranged from 22.2 to 50%. In the open trial
of Signorini et al. [31
&
], an attrition rate of 50% was
reported, whereas the other open trial [30] reported
a substantially lower rate (25%) of noncompleters.
In four of the RCTs, the rate of noncompleters was
similar, ranging from 22.2 [25
&&
] to 26.2% [27
&&
]. In
the RCT of Wade et al. [29], 30% of the participants
did not complete treatment.Analysis
All reported results are based on an intention-to-
treat analysis.
Randomized controlled trials
Of the five RCTs, three reported significant differ-





,29]. Wade et al. [29] found that the firstTable 2. Changes in Eating Disorder Examination Questionnaire
Ref. N
Pre-treatment
Mean Global EDE(-Q) (SD)
Dalle Grave et al. [30] 68 3.6 (1.5)
Signorini et al. [31&] 108 4.03 (1.29)
Wade et al. [29] 39 4.37 (1.19)
EDE, Eating Disorder Examination; EDE-Q, Eating Disorder Examination Questionna
aSignificant at P<0.05.
6 www.co-psychiatry.com8 weeks of group CBT-E were more effective in terms
of reducing EDE-Q global scores compared with no
treatment. In the study of Fairburn et al. [27
&&
], the
levels of eating disorder psychopathology decreased
(global EDE score) in both conditions (CBT-E and
IPT); however, the changes were significantly
greater among CBT-E participants. The percentage
of CBT-E participants in remission was almost twice
as high as that in participants who received IPT (65.5
vs. 33.3%). In the study of Poulsen et al. [25
&&
], there
was a large variation in treatment duration (5
months CBT-E vs. 24 months psychoanalytic psy-
chotherapy). Significant differences were found
between groups for binge eating and purging;
42% of the patients in CBT-E had ceased binge
eating and purging (after 5 months) compared
with 15% of the patients in psychoanalytic psycho-
therapy (after 24 months). By the end of both
treatments, although there were substantial
improvements in eating disorder psychopathology
(global EDE scores), these changes took place more
rapidly in CBT-E. In two out of five RCTs, no signifi-
cant differences were found. In the study of Thom-
son-Brenner et al. [28
&
], two versions of CBT-E were
compared (focused version vs. broad version). The
groups did not differ in primary outcome and the
remission rate of the total sample was 42%. In
addition, in the study of Wonderlich et al. [26
&
],
comparing CBT-E with ICAT, no significant differ-
ences in treatment outcome were found between
groups.Open trials
In both open trials, there was a significant decrease
in EDE-Q scores [30,31
&
] (Table 2). Dalle Grave et al.
[30] reported a remission rate of 67.6%; however, a
substantial percentage of their patients (25%) met
the criteria for remission before treatment started.
Signorini et al. [31
&
] used two different definitions
of remission and reported a remission rate of 42.2
and 35.4%, respectively. As mentioned, in the study
of Wade et al. [29], a control condition was included
only in the first 8 weeks; after having received a full
dosage of CBT-E, the remission rate for all patientsglobal score in open trials: intention-to-treat analysis
Post-treatment
Mean Global EDE(-Q) (SD)
Follow-up
Mean Global EDE(-Q) (SD)
1.8 (1.8)a -
3.09 (1.76)a 3.10 (1.76)
2.36 (1.31)a 2.67 (1.44)
ire; SD, standard deviation.
Volume 32  Number 00  Month 2018
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Enhanced cognitive behavioural therapy de Jong et al.(whether in the experimental or control group) was
66.7% (Table 1).
Differences in outcome, in RCTs and open trials,
are explained in part by differences in the definition
of clinical significant change and in the level of the
EDE-Q community mean (Table 1).Follow-up
Of the seven included studies, five had a follow-up
assessment period varying from 3 months [29],
4 months [26
&
], 20 weeks [31
&





]. Generally, in most studies, the
posttreatment results were maintained during fol-
low-up. In the study of Wade et al. [29], during
follow-up, the percentage ‘good outcome’ decreased
from 66.7 to 46.2%. In the study of Fairburn et al.
[27
&&
], the proportion of participants meeting the
criteria for remission during follow-up increased
in the IPT condition (33.3 to 49.0%), but the rate
remained higher (69.4%) in CBT-E.Assessing quality and variability in
psychological treatment trials: the Clinical
Trial Assessment Measure
We used the CTAM [23] to assess the methodologi-
cal quality of the included RCTs (see Materials and
methods). Three of the five RCTs had a similarly







good methodological quality. One of the RCTs
described the process of assessor blinding [28
&
],
but none of them verified the blinding of assessors
at the end of the study. In the study of Thompson-
Brenner et al. [28
&
], due to the small sample size and
lack of measurement of treatment quality, the
CTAM score was 7 points lower. Compared with
the other four RCTs, the trial of Wade et al. [29]
had a lower CTAM score; this latter study had a small
sample size, no independent randomization, no
description of randomization, no active control
condition and no assessment of treatment quality.
A full description and ratings of the CTAM are
available on request from the first author.DISCUSSION
The findings of this systematic review of seven
effectiveness studies (five RCTs and two open trials)
replicate and extend findings from two earlier stud-
ies [21,22], demonstrating that CBT-E is an effective
treatment for bulimia nervosa, BED and transdiag-
nostic samples of adult patients with an eating
disorder. Since 2014, several RCTs made a direct
comparison between CBT-E and other active
treatment conditions, such as interpersonal0951-7367 Copyright  2018 The Author(s). Published by Wolters Kluwepsychotherapy (IPT), psychoanalytic psychother-
apy and integrative cognitive-affective therapy
(ICAT). Although IPT is also an established evi-
dence-based treatment for bulimia nervosa and
BED [35], the first direct comparisonmade between
IPT and CBT-E in a transdiagnostic eating disorder
sample, showed that CBT-E was more effective
[27
&&
]. In another comparison in a bulimia nervosa
sample, 20 weeks of CBT-E was compared with
2 years of psychoanalytic psychotherapy [25
&&
]. At
the end of treatment, the considerable difference in
remission rates of binge eating and purging in
favour of CBT-E (in combination with the substan-
tial differences in treatment duration) demon-
strates that CBT-E for bulimia nervosa is highly
cost-effective compared with psychoanalytic psy-
chotherapy. One study was the first to show that
ICAT (a new psychotherapeutic treatment for
bulimia nervosa) might be as effective as CBT-E
[26
&
]. Furthermore, group CBT-E seems to be an
acceptable alternative to individual CBT-E [29]. In
a bulimia nervosa samplewith comorbid borderline
personality disorder, no difference in effect was
found between the focused and the broad version
of CBT-E [28
&
]. The study of Dalle Grave et al. [30]
showed that CBT-E might be a potential treatment
approach for nonunderweight adolescents with an
eating disorder. Although Family-BasedTreatment
(FBT) is the preferred treatment for adolescentswith
bulimia nervosa [36], CBT-E might be a possible
alternative when, for example, FBT is not suffi-
ciently effective or not available. Finally, the study
of Signorini et al. [31
&
] showed that CBT-E is gener-
alizable to a noncontrolled clinical context. How-
ever, that study had a high attrition rate of up
to 50%, possibly due to the high percentage of
participants with anorexia nervosa (20.8%) in their
sample. In an earlier open trial [22] with a trans-
diagnostic sample including anorexia nervosa, the
attrition rate was also high (40%).
In this review, substantial differences were
found in posttreatment remission rates (22.2–
67.6%); when interpreting these differences, several
issues need to be considered. First, studies are diffi-
cult to compare due to variation in the included
samples, differences in the definition of clinical
significant change and differences in the methodo-
logical quality of the studies. For example, in the
study of Dalle Grave et al. [30], the high proportion
that met the criteria for remission at baseline (25%)
biases the relatively high posttreatment remission
rate (67.6%). Also, the difference in ‘good outcome’
between the studies ofWade et al. [29] and Signorini
et al. [31
&
], both carried out in Australia, can be
explained, in part, by the different EDE-Q com-
munity mean used for the definition of clinicalr Health, Inc. www.co-psychiatry.com 7
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Eating disorderssignificant change. Signorini et al. [31
&
] found a
posttreatment remission rate of 42.2% (EDE-Q score
2.46), whereas Wade et al. [29] reported 66.7%
(EDE-Q score 2.77).
Moreover, differences between the studies are
not always easy to explain. For example, the sub-
stantial difference in outcome of CBT-E between the
study of Poulsen et al. [25
&&
], with a posttreatment
abstinence rate of 42% compared with the 22.5%
reported by Wonderlich et al. [26
&
] is puzzling, as
both studies are similar regarding their samples,
operationalization of clinical significant change
(abstinence of binge eating/purging) and both are
of good quality. One difference between these stud-
ies is that, in the study of Poulsen et al. [25
&&
], the
founder of CBT-E was closely involved in the train-
ing and supervision of the therapists. Another
is how completion was operationalized. Poulsen
et al. [25
&&
] defined completion as finishing the
complete treatment, whereas Wonderlich et al.
[26
&
] defined completion as attending at least
16 sessions.
A strong point of the present study is that it is
the first review on CBT-E to assess the methodologi-
cal quality of the included RCTs. Moreover, the
results of this assessment indicate that, overall,
the quality of the studies was high.
Taken together, the effectiveness studies of CBT-
E for bulimia nervosa, BED and transdiagnostic
samples (published since January 2014), of which
four RCTs with high methodological quality, pro-
vide additional and robust evidence that CBT-E
is indeed an effective treatment for patients with
eating disorders.
This systematic review excluded CBT-E trials,
which studied patients with anorexia nervosa alone;
however, the two open studies with transdiagnostic
samples also included patients with anorexia nerv-
osa [29,31
&
]. Although these latter studies show
positive effects of CBT-E in these samples, the
anorexia nervosa subgroups were not analysed sep-
arately. Also, although CBT-E has been described as
promising for the treatment of anorexia nervosa





In an open trial, preliminary support was found for
the use of CBT-E for anorexia nervosa [37]. In a
subsequent implementation study of CBT-E for out-
patients with anorexia nervosa, half of the patients
did not complete CBT-E, whereas the remaining
patients achieved a significant increase in BMI at
1-year follow-up [40
&
]. In an open study among
inpatients with anorexia nervosa, Calugi et al.
[41
&
] found that CBT-E was well accepted and might
be a viable and promising treatment, even for those
with severe and enduring anorexia nervosa. Overall
treatment results of CBT-E for anorexia nervosa were8 www.co-psychiatry.compoorer than CBT-E for other eating disorders; how-
ever, this finding needs to be interpreted in the
broader context of treatment studies on anorexia
nervosa with overall poor posttreatment outcome
[42].
Some recommendations can be made for future
research. A trial with a direct comparison between
CBT-E and another CBT protocol might help
unravel the differential effects of CBT-E, and studies
on the working mechanisms of CBT-E could
strengthen its theoretical foundation. On the basis
of our results, we also recommend that researchers
facilitate comparability between CBT-E studies.
Agreement should be reached concerning, for exam-
ple, what outcome variable to use to establish clini-
cal significant change, what level of competence
is needed for a CBT-E therapist, what tool should
be used to measure treatment integrity and what
specifically constitutes ‘not completed’ therapy.
This review has some limitations. First, the lit-
erature search and identification of relevant studies
was done by one researcher (first author), implying
that studies might have been missed and/or study
characteristics or results may have been misinter-
preted. Second, for practical reasons, only studies in
the English language were included. Finally, the
literature search was restricted to Medline, Psy-
cINFO and Embase; although we tried to address
this limitation by examining the reference lists of
earlier meta-analyses and of the articles in this
review, eligible articles may unintentionally have
been missed.CONCLUSION
There is robust evidence that CBT-E is an effective
treatment for adult patients with an eating disorder,
especially for bulimia nervosa, BED and OSFED.
Future research on the working mechanisms and
differential effects of CBT-E compared with other
CBT protocols might reveal the theoretical founda-
tions and specificity of CBT-E. To establish good
comparability between studies, we recommend that
agreement be made between researchers, in particu-
lar regarding the operationalization of clinical sig-
nificant change and the use of standard definitions.Acknowledgements
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